Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Development of Reference Control Material for the Evaluation of the Cepheid Prototype * Xpert® BCR-ABL P190 Ultra Assay

Yuanyuan Liu, PhD, Tran Tran, BS, Phat Nguyen, BSc, Huilin Wei, MD PhD, Gwo-Jen Day, PhD, Lin Yuan, MS

Blood (2019) 134 (Supplement_1): 5213.

https://doi.org/10.1182/blood-2019-128856

Published: 2019

Journal Articles

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Blood (2019) 134 (Supplement_1): 2891.

https://doi.org/10.1182/blood-2019-126927

Published: 2019

Journal Articles

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Austin Christofferson, BSc, Sheri Skerget, PhD, Jessica Aldrich, Christophe Legendre, PhD, Sara Nasser, PhD, Jennifer Yesil, Daniel Auclair, The MMRF CoMMpass Network, Sagar Lonial, Jonathan J Keats, PhD

Blood (2019) 134 (Supplement_1): 1805.

https://doi.org/10.1182/blood-2019-132152

Published: 2019

Journal Articles

Prognostic Impact of MYC Oncoprotein Expression on Survival Outcome in Secondary AML Patients

Seongseok Yun, MD PhD, Rohit Sharma, MD, David A Sallman, MD, Nicole D. Vincelette, PhD, Kendra L. Sweet, MD, Eric Padron, MD, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Lynn C. Moscinski, MD, John Cleveland, PhD, Alan F. List, MD, Ling Zhang, MD

Blood (2018) 132 (Supplement 1): 2756.

https://doi.org/10.1182/blood-2018-99-120048

Published: 2018

Journal Articles

Advances in Biomagnetic Liver Susceptometry Allow the Measurement of Liver Iron Concentration with a Room Temperature Sensor

Ashutosh Lal, MD, William Avrin, PhD, Viktoriia Kolotovska, MS, Lisa Calvelli, MS, Marcela Weyhmiller, PhD

Blood (2018) 132 (Supplement 1): 4890.

https://doi.org/10.1182/blood-2018-99-117355

Published: 2018

Journal Articles

Spatially Resolved, Multiplexed Digital Characterization of Protein Distribution and Abundance in Formalin-Fixed, Paraffin-Embedded (FFPE) Diffuse Large B Cell Lymphoma Tissue Sections Based on the Nanostring® Digital Spatial Profiling (DSP) Technology

Andrew White, Nathan Elliott, PhD, Yan Liang, PhD, Sarah E. Warren, PhD, Joseph M. Beechem, PhD

Blood (2017) 130 (Supplement 1): 1196.

https://doi.org/10.1182/blood.V130.Suppl_1.1196.1196

Published: 2017

Journal Articles

A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

Blood (2017) 130 (Supplement 1): 158.

https://doi.org/10.1182/blood.V130.Suppl_1.158.158

Published: 2017

Journal Articles

Precision in PD-L1 Assessment in Diffuse Large B Cell Lymphoma: Greater Biological Insight Using in Situ Hybridization Approach

Imran Siddiqi, MDPhD, Venkata Thodima, PhD, Kishor Bhatia, PhD, Jane Houldsworth, PhD, Rita Shaknovich, MD PhD

Blood (2017) 130 (Supplement 1): 1477.

https://doi.org/10.1182/blood.V130.Suppl_1.1477.1477

Published: 2017

Journal Articles

PD-L1 Expression Identifies High Risk Diffuse Large B-Cell Lymphoma and Is Associated with Several Genomic Markers

Imran N Siddiqi, MD PhD, Venkata Thodima, PhD, Julia Friedman, PhD, Adames Violeta, Anil Tulpule, MD, Rita Shaknovich, MD PhD, Jane Houldsworth, PhD

Blood (2016) 128 (22): 153.

https://doi.org/10.1182/blood.V128.22.153.153

Published: 2016

Journal Articles

Analytical Assessment of an IVD Multiplex BCR-ABL1 Monitoring Assay Directly Aligned to the WHO Primary Standards and Reporting on Two Continuous Scales (%IS and MR)

John Longshore, PhD, Heather Amidon, Kyoko Kushiro, Ion Beldorth, Scott A. Shell, PhD, Justin T. Brown, PhD

Blood (2016) 128 (22): 5443.

https://doi.org/10.1182/blood.V128.22.5443.5443

Published: 2016

Journal Articles

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

B. Uelker, Ian Cushman, PhD, T. Dudek, Dr. Matthias Herkert, PhD, Dr. Cyril E. Geacintov, PhD

Blood (2016) 128 (22): 4820.

https://doi.org/10.1182/blood.V128.22.4820.4820

Published: 2016

Journal Articles

Reinvestigation of the T-Cell Inactivation Achieved for the Prevention of TA GV HD By 2500 Gy of Gamma Irradiation, a Comparison with Pathogen Reduction

Patricia A Merkel, Hannah E Giclas, Andrew Gibula, Gillian Andersen, Vijaya Knight, Jin-Sying Lin, Grace Castro, Jennifer Green, Adonis Stassinopoulos

Blood (2016) 128 (22): 1455.

https://doi.org/10.1182/blood.V128.22.1455.1455

Published: 2016

Journal Articles

Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma

David M. Kurtz, MD, Florian Scherer, MD, Aaron M. Newman, PhD, Alexander F. Lovejoy, PhD, Daniel M. Klass, PhD, Jacob J. Chabon, Sanjiv Gambhir, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2015) 126 (23): 130.

https://doi.org/10.1182/blood.V126.23.130.130

Published: 2015

Journal Articles

Defining Primary Marrow Microenvironment-Induced Synthetic Lethality and Resistance for 2,684 Approved Drugs Across Molecularly Distinct Forms of Multiple Myeloma

Megan Murnane, M.Sc., Eugen Dhimolea, PhD, Ruojing Li, BS, Megan A. Bariteau, BSc, Diamond D. Wheeler, BS, Rosemary J. Akhurst, PhD, Aaron C. Logan, MD PhD, Pamela Munster, MD, Arun Wiita, MD PhD, Thomas G. Martin, III, MD, Jeffrey L. Wolf, MD PhD, Jun O. Liu, PhD, Constantine S. Mitsiades, MD PhD, Blake T. Aftab, PhD

Blood (2015) 126 (23): 503.

https://doi.org/10.1182/blood.V126.23.503.503

Published: 2015

Journal Articles

Clinical Evaluation of Xpert® BCR-ABL Ultra, an Automated and Standardized Cartridge-Based Assay for the Quantification of BCR-ABL1

Michael J. Mauro, MD, Richard D. Press, MD PhD, David S. Snyder, MD, Qin Huang, MD PhD, Javier Pinilla-Ibarz, Dahui Qin, MD PhD, Christina Lockwood, PhD, Jacqueline E. Payton, MD PhD, Geoffrey L. Uy, MD, Matt E. Kalaycio, MD, Ramon V. Tiu, MD BS, Vivian Oehler, MD, Gwo-Jen Day, PhD, Wendy Wong, Michael P. Bates, MD, Jerald P. Radich

Blood (2015) 126 (23): 5170.

https://doi.org/10.1182/blood.V126.23.5170.5170

Published: 2015

Journal Articles

Development of Xpert® BCR-ABL Ultra, an Automated and Standardized Multiplex Assay with Required Performance Characteristics for BCR-ABL1 Quantitative Measurement on an International Reporting Scale

Gwo-Jen Day, PhD, Christina Lockwood, PhD, Jacqueline E. Payton, MD PhD, Geoffrey L. Uy, MD, Charles Schiffer, Gerald Feldman, MD PhD FACMG, Aaron Bossler, MD PhD, Julie Woolworth, PhD, Alice S. Mims, MD, Alba Levitas, Krupa Shridhar, Sandy Huang, Vivian Xiao, PhD, Natalie Wu, PhD, Michael P. Bates, MD, Wendy Wong

Blood (2015) 126 (23): 2793.

https://doi.org/10.1182/blood.V126.23.2793.2793

Published: 2015

Journal Articles

Comprehensive Quantitative RT-PCR Detection of Multiple BCR-ABL1 mRNA Species for Diagnosis and Monitoring of Leukemias

Ming Mai, MS, Rong He, MD, David S. Viswanatha, MD

Blood (2014) 124 (21): 4555.

https://doi.org/10.1182/blood.V124.21.4555.4555

Published: 2014

Journal Articles

MicroRNA Dysregulation in Newly Diagnosed Chronic Myeloid Leukaemia Patients

Jane E. A. Gordon, B Med, Charles G Bailey, PhD, John Rasko, MBBS, PhD, William Ritchie, PhD, Dale B. Watkins, B.Sc. (Hons), Deborah L. White, PhD, FFSc(RCPA), Tamara Leclercq, PhD, Timothy P Hughes, MD, MBBS

Blood (2013) 122 (21): 4985.

https://doi.org/10.1182/blood.V122.21.4985.4985

Published: 2013

Journal Articles

Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Julie Toplin, Kristy Drafahl, Jonathan Eibl, Clark Fjeld, Thomas Yager, Staci McAdams, Kevin Hawkins, Chad Galderisi

Blood (2013) 122 (21): 2617.

https://doi.org/10.1182/blood.V122.21.2617.2617

Published: 2013

Journal Articles

Leveraging The Old With The New: Exploring and Integrating Historic Microarray Studies With Next Generation Sequencing For Multiple Myeloma

Michael A Bauer, PhD, Erich A Peterson, PhD, Shweta S. Chavan, PhD, Daniel Pollock, BS, Christoph Heuck, MD, Donald Johann, MD, MS

Blood (2013) 122 (21): 3122.

https://doi.org/10.1182/blood.V122.21.3122.3122

Published: 2013

NARROW

Development of Reference Control Material for the Evaluation of the Cepheid Prototype * Xpert® BCR-ABL P190 Ultra Assay

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Unsupervised Clustering of DNA Copy Number Profiles Identifies a High-Risk Subtype of Hyperdiploid Multiple Myeloma: An Mmrf Commpass Analysis

Prognostic Impact of MYC Oncoprotein Expression on Survival Outcome in Secondary AML Patients

Advances in Biomagnetic Liver Susceptometry Allow the Measurement of Liver Iron Concentration with a Room Temperature Sensor

Spatially Resolved, Multiplexed Digital Characterization of Protein Distribution and Abundance in Formalin-Fixed, Paraffin-Embedded (FFPE) Diffuse Large B Cell Lymphoma Tissue Sections Based on the Nanostring® Digital Spatial Profiling (DSP) Technology

A Prognostic Classifier Based on Early Platelet Drop in Lower-Risk MDS. a Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

Precision in PD-L1 Assessment in Diffuse Large B Cell Lymphoma: Greater Biological Insight Using in Situ Hybridization Approach

PD-L1 Expression Identifies High Risk Diffuse Large B-Cell Lymphoma and Is Associated with Several Genomic Markers

Analytical Assessment of an IVD Multiplex BCR-ABL1 Monitoring Assay Directly Aligned to the WHO Primary Standards and Reporting on Two Continuous Scales (%IS and MR)

High Sensitivity Hepcidin-25 Bioactive Elisas: Manual and Fully Automated System for the Quantification of Hepcidin-25 in Human Serum and Plasma

Reinvestigation of the T-Cell Inactivation Achieved for the Prevention of TA GV HD By 2500 Gy of Gamma Irradiation, a Comparison with Pathogen Reduction

Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma

Defining Primary Marrow Microenvironment-Induced Synthetic Lethality and Resistance for 2,684 Approved Drugs Across Molecularly Distinct Forms of Multiple Myeloma

Clinical Evaluation of Xpert® BCR-ABL Ultra, an Automated and Standardized Cartridge-Based Assay for the Quantification of BCR-ABL1

Development of Xpert® BCR-ABL Ultra, an Automated and Standardized Multiplex Assay with Required Performance Characteristics for BCR-ABL1 Quantitative Measurement on an International Reporting Scale

Comprehensive Quantitative RT-PCR Detection of Multiple BCR-ABL1 mRNA Species for Diagnosis and Monitoring of Leukemias

MicroRNA Dysregulation in Newly Diagnosed Chronic Myeloid Leukaemia Patients

Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Leveraging The Old With The New: Exploring and Integrating Historic Microarray Studies With Next Generation Sequencing For Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only